Astellas Pharma (STU:YPH) PensionAndRetirementBenefit : €152 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Astellas Pharma PensionAndRetirementBenefit?

Astellas Pharma's PensionAndRetirementBenefit for the quarter that ended in Mar. 2024 was €152 Mil.

Astellas Pharma's quarterly PensionAndRetirementBenefit increased from Sep. 2023 (€155 Mil) to Dec. 2023 (€169 Mil) but then declined from Dec. 2023 (€169 Mil) to Mar. 2024 (€152 Mil).

Astellas Pharma's annual PensionAndRetirementBenefit declined from Mar. 2022 (€285 Mil) to Mar. 2023 (€173 Mil) and declined from Mar. 2023 (€173 Mil) to Mar. 2024 (€152 Mil).

Astellas Pharma PensionAndRetirementBenefit Historical Data

The historical data trend for Astellas Pharma's PensionAndRetirementBenefit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Astellas Pharma PensionAndRetirementBenefit Chart

Astellas Pharma Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

PensionAndRetirementBenefit

Get a 7-Day Free Trial

320.03

301.24

285.06

173.42

151.52

Astellas Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
PensionAndRetirementBenefit	Get a 7-Day Free Trial															173.42	177.15	155.32	168.97	151.52

Astellas Pharma PensionAndRetirementBenefit Calculation

PensionAndRetirementBenefit is the carrying amount as of the balance sheet date of the portion of the obligations recognized for the various benefits provided to former or inactive employees, their beneficiaries, and covered dependents after employment but before retirement.

Astellas Pharma (STU:YPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Astellas Pharma Inc (STU:YPH) » Definitions » PensionAndRetirementBenefit

Comparable Companies

Traded in Other Exchanges

ALPMY:USA ALPMF:USA 4503:Mexico 4503:Japan YPHA:Germany

Address

2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, JPN, 103-8411

Website

http://www.astellas.com

Astellas Pharma Inc is a drug manufacturing company that sells pharmaceutical products across the globe. The vast majority of the company's revenue is derived from Japanese markets, followed by the Americas. Royalty income makes up a small percentage of Astellas' overall sales. Its largest therapeutic area by sales composition is oncology, followed by urology and transplantation. The company uses mergers and acquisitions as part of its long-term growth strategy. Astellas enters into strategic partnerships and licensing agreements to strengthen its commercialization platforms.

Astellas Pharma (STU:YPH) Headlines

No Headlines